Tin tức & Cập nhật
Lọc theo Chuyên ngành:
GLP-1RA users face no elevated risk of pancreatic cancer
Among individuals with type 2 diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) does not contribute to increased pancreatic cancer risk, according to a study.
GLP-1RA users face no elevated risk of pancreatic cancer
16 Jan 2024
Voice-based AI makes insulin management a breeze for T2D patients
A voice-based conversational artificial intelligence application helps type 2 diabetes (T2D) patients navigate basal insulin titration at home and, in turn, achieve rapid glycaemic control, as reported in a study.
Voice-based AI makes insulin management a breeze for T2D patients
13 Jan 2024
Semaglutide trims down weight in patients with severe obesity
Use of semaglutide 2.4 mg results in substantial weight reduction in patients with severe obesity who had previously undergone bariatric surgery (BS) but failed to achieve satisfactory weight loss, reports a recent study.
Semaglutide trims down weight in patients with severe obesity
12 Jan 2024
New models predict skeletal muscle mass reduction with calorie restriction
A recent study has shown that healthy men and women with overweight or obesity who undergo voluntary calorie restriction (CR), without a structure exercise program, attain decreases in skeletal muscle (SM) mass of approximately 2 to 2.5 kg and 1 to 1.5 kg per 10-kg weight loss, respectively.